1Zeng MS,Li DJ,Liu QL,et al.Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient[J].J Virol,2005,79(24):15323-15330.
2Cheng WM,Chan KH,Chen HL,et al.Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum[J].Int J Cancer,2002,97(4):489-492.
7Zeng MS, Li DJ, Liu QL, et al. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient [J]. J Virol, 2005,79(24) : 15323-15330.
8Cheng WM, Chan KH, Chen HL, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum [J]. Int J Cancer, 2002,97(4):489-492.
9Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein-Barr viral DNA in serum of patient with nasopharyngeal carcinoma [ J ]. Clin Cancer Res, 1998,4 (3) : 665-669.
10Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma [J]. Cancer Res, 1999,59(6): 1188-1191.
